Cover Story
EN April 2023 Cover

The Price Is (Finally) Right

Recent insulin price cuts are a dose of good news.  

Read More

Features

  • The Agonists and the Ecstasy

    The popularity of GLP-1 agonists to treat obesity has been skyrocketing in recent months, leading to both shortages and price increases. Ho...

    Read More

Departments

President's Viewpoint

More

Trends and Insights

More